[Investor Update] Pharmasaga Oversubscribes Pre-A Round Funding Goal

Pharmasaga achieved remarkable success at the Demo Day hosted by Honsun Precision and H. Spectrum+.

Our development focus was highly favored by both domestic and international investment advisory firms and key opinion leaders in the biomedical field. This strong interest not only allowed us to achieve our Pre-A round funding goal ahead of schedule but also enabled us to secure the maximum limit for this fundraising round.

We sincerely thank all our investors for their support. The Company regards every investor as a partner and will continue to uphold a diligent and earnest attitude to successfully conduct and achieve our clinical trial milestones.